Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(5):426–432. doi: 10.1002/clc.4960200505

Coronary risk factors, endothelial function, and atherosclerosis: A review

Robert A Vogel 1,✉
PMCID: PMC6656192  PMID: 9134272

Abstract

The traditional risk factors for coronary heart disease, which include hypercholesterolemia, hypertension, cigarette smoking, diabetes mellitus, and high‐fat diet, have all been associated with impairments in endothelial function. Impaired endothelium function may promote the development of atherosclerosis through its effects on vasoregulation, platelet and monocyte adhesion, vascular smooth muscle cell growth, and coagulation. Increased oxidative stress may be another mechanism by which endothelial dysfunction contributes to atherosclerosis, although controversy exists on this issue. Risk factor modification, particularly lowering elevated concentrations of low‐density lipoprotein cholesterol, improves endothelial function. At least seven clinical studies have demonstrated improved endothelial function with cholesterol reductions in patients with markedly elevated or even borderline elevations in cholesterol concentrations, whether or not coronary heart disease is present. Other interventions that improve endothelial function include blood pressure reduction, smoking cessation, and administration of estrogen to postmenopausal women.

Keywords: atherosclerosis, cholesterol, coronary heart disease, endothelial dysfunction, low‐density lipoprotein cholesterol, risk factors

Full Text

The Full Text of this article is available as a PDF (846.2 KB).

References

  • 1. Levine GN, Keaney JF Jr, Vita JA: Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512–521 [DOI] [PubMed] [Google Scholar]
  • 2. Glasser SP, Selwyn AP, Ganz P: Atherosclerosis: Risk factors and the vascular endothelium. Am Heart J 1996; 131: 379–384 [DOI] [PubMed] [Google Scholar]
  • 3. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low‐density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924 [DOI] [PubMed] [Google Scholar]
  • 4. Simon BC, Cunningham LD, Cohen RA: Oxidized low density lipoproteins cause contraction and inhibit endothelium‐dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75–79 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R, Tanouchi J, Hon M, Inoue M, Kamada T: Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessible with intravascular ultrasound. Am Heart J 1996; 131: 231–238 [DOI] [PubMed] [Google Scholar]
  • 6. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27–36 [DOI] [PubMed] [Google Scholar]
  • 7. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor responses to acetylcholine relate to risk factors for coronary artery disease. Circulation 1990; 81: 491–497 [DOI] [PubMed] [Google Scholar]
  • 8. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP: Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88 (part 1): 2139–2148 [DOI] [PubMed] [Google Scholar]
  • 9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE: Endothelium‐dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474 [DOI] [PubMed] [Google Scholar]
  • 10. Leung W‐H, Lau C‐P, Wong C‐K: Beneficial effect of cholesterol‐lowering therapy on coronary endothelium‐dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341: 1496–1500 [DOI] [PubMed] [Google Scholar]
  • 11. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A: Reduction in serum cholesterol with pravastatin improves endothelium‐dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519–2524 [DOI] [PubMed] [Google Scholar]
  • 12. Anderson TJ, Meredith IT, Yeung AC: The effect of cholesterol‐lowering and antioxidant therapy on endothelium‐dependent coronary vasomotion. N Engl J Med 1995; 332: 488–493 [DOI] [PubMed] [Google Scholar]
  • 13. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarhold JC, Alexander RW: Beneficial effects of cholesterol‐lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481–487 [DOI] [PubMed] [Google Scholar]
  • 14. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ: Vascular function in the forearm of hypercholesterolaemic patients off and on lipid‐lowering medication. Lancet 1995; 346: 467–471 [DOI] [PubMed] [Google Scholar]
  • 15. Vogel RA, Corretti MC, Plotnick GD: Changes in flow‐mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle‐aged men. Am J Cardiol 1996; 77: 37–40 [DOI] [PubMed] [Google Scholar]
  • 16. Seiler C, Suter TM, Hess OM: Exercise‐induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol‐lowering drag therapy with bezafibrate. J Am Coll Cardiol 1995; 26: 1615–1622 [DOI] [PubMed] [Google Scholar]
  • 17. Cayatte AJ, Palacino JJ, Horten K, Cohen RA: Chronic inhibition of nitric oxide production accelerates neointimal formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753–759 [DOI] [PubMed] [Google Scholar]
  • 18. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche J‐M, Dupuis B, Bertrand ME: Long‐term oral administration of L‐arginine reduces intimal thickening and enhances neoendothelium‐dependent acetylcholine‐induced relaxation after arterial injury. Circulation 1994; 90: 1357–1362 [DOI] [PubMed] [Google Scholar]
  • 19. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376 [DOI] [PubMed] [Google Scholar]
  • 20. Lerman A, Burnett JC Jr: Intact and altered endothelium in regulation of vasomotion. Circulation 1992; 86 (suppl III): III‐12–III‐19 [PubMed] [Google Scholar]
  • 21. Flavahan NA: Atherosclerosis or lipoprotein‐induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927–1938 [DOI] [PubMed] [Google Scholar]
  • 22. Moncada S, Higgs A: The L‐arginine‐nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012 [DOI] [PubMed] [Google Scholar]
  • 23. Stiko‐Rahm A, Wiman B, Hamsten A, Nilsson J: Secretion of plasminogen activator inhibitor‐1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067–1073 [DOI] [PubMed] [Google Scholar]
  • 24. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T: Flow‐dependent coronary artery dilation in humans. Circulation 1989; 80: 466–474 [DOI] [PubMed] [Google Scholar]
  • 25. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115 [DOI] [PubMed] [Google Scholar]
  • 26. Corretti MC, Plotnick GD, Vogel RA: Technical aspects of evaluating brachial artery vasodilation using high‐frequency ultrasound. Am J Physiol 1995; 268 ( Heart Circ Physiol 37 ):H1397–H1404 [DOI] [PubMed] [Google Scholar]
  • 27. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP: Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241 [DOI] [PubMed] [Google Scholar]
  • 28. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E: Impaired endothelium‐dependent vasodilation of coronary resistance vessels is associated with exercise‐induced myocardial ischemia. Circulation 1995; 91: 2345–2352 [DOI] [PubMed] [Google Scholar]
  • 29. Quyyumi, AA, Cannon RO III, Panza JA, Diodati JG, Epstein SE: Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 1864–1871 [DOI] [PubMed] [Google Scholar]
  • 30. Vogel RA: Endothelium‐dependent vasoregulation of coronary artery diameter and blood flow. Circulation 1993; 88: 325–327 [DOI] [PubMed] [Google Scholar]
  • 31. Penny WF, Rockman H, Long J, Bhargava V, Carrigan K, Ibriham A, Shabetai R, Ross J Jr, Peterson KL: Heterogeneity of vasomotor response to acetylcholine along the human coronary artery. J Am Coll Cardiol 1995; 25: 1046–1055 [DOI] [PubMed] [Google Scholar]
  • 32. El‐Tamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky RA, Conti CR, Pepine CJ: Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Circulation 1994; 89: 45–51 [DOI] [PubMed] [Google Scholar]
  • 33. Kuo L, Davis MJ, Chilian WM: Longitudinal gradients for endothelium‐dependent and ‐independent vascular responses in the coronary microcirculation. Circulation 1995; 92: 518–525 [DOI] [PubMed] [Google Scholar]
  • 34. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A: Effect of inhibition of nitric oxide syntheses on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993; 88: 43–54 [DOI] [PubMed] [Google Scholar]
  • 35. Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G: Nitric oxide production by coronary conductance vessels in hypercholesterolemia patients. Am Heart J 1996; 131: 1051–1057 [DOI] [PubMed] [Google Scholar]
  • 36. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO III: Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994; 90: 35–41 [DOI] [PubMed] [Google Scholar]
  • 37. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–1051 [DOI] [PubMed] [Google Scholar]
  • 38. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B: Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287–291 [DOI] [PubMed] [Google Scholar]
  • 39. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP: Loss of flow‐mediated endothelium‐dependent dilation occurs early in the development of atherosclerosis. Circulation 1991; 84: 1273–1278 [DOI] [PubMed] [Google Scholar]
  • 40. Reddy KG, Nair RN, Sheehan HM, Hodgson JMcB: Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23: 833–843 [DOI] [PubMed] [Google Scholar]
  • 41. Zieher AM, Drexler H, Wollschlager H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984–1992 [DOI] [PubMed] [Google Scholar]
  • 42. Benzuly KH, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD: Functional improvement precedes structural regression of atherosclerosis. Circulation 1994; 89: 1810–1818 [DOI] [PubMed] [Google Scholar]
  • 43. Plotnick GD, Corretti MC, Vogel RA: Transient impairment of endothelium‐dependent brachial artery vasoactivity following a fatty meal (abstr). J Am Coll Cardiol 1996; 27: 287A [PubMed] [Google Scholar]
  • 44. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE, Chir B: Cigarette smoking is associated with dose‐related and potentially reversible impairment of endothelium‐dependent dilation in healthy young adults. Circulation 1993; 88: 2149–2155 [DOI] [PubMed] [Google Scholar]
  • 45. Hornig B, Maier V, Drexler H: Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210–214 [DOI] [PubMed] [Google Scholar]
  • 46. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA: Estrogen improves endothelium‐dependent, flow‐mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936–941 [DOI] [PubMed] [Google Scholar]
  • 47. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III: Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786–791 [DOI] [PubMed] [Google Scholar]
  • 48. Osborne JA, Seigman MJ, Sedar AW, Mooers SU, Lefer AM: Lack of endothelium‐dependent relaxation in coronary resistance arteries of cholesterol‐fed rabbits. Am J Physiol 1989; 256: C591–C597 [DOI] [PubMed] [Google Scholar]
  • 49. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228–234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Chowienczyk, PJ , Watts GF, Cockcroft JR, Ritter JM: Impaired endothelium‐dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430–1432 [DOI] [PubMed] [Google Scholar]
  • 51. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA: The role of nitric oxide in endothelium‐independent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541–2547 [DOI] [PubMed] [Google Scholar]
  • 52. Goode GK, Heagerty AM: In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995; 91: 2898–2903 [DOI] [PubMed] [Google Scholar]
  • 53. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium‐dependent‐relaxation by lysolecithin in modified low‐density lipoproteins. Nature 1990; 344: 160–162 [DOI] [PubMed] [Google Scholar]
  • 54. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546–2551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA: Investigation of decreased availability of nitric oxide percursor as the mechanism responsible for impaired endothelium‐dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol 1994; 23: 844–850 [DOI] [PubMed] [Google Scholar]
  • 56. Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP, Ganz P: Endothelium‐dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93: 1647–1650 [DOI] [PubMed] [Google Scholar]
  • 57. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107–1113 [DOI] [PubMed] [Google Scholar]
  • 58. Weber C, Erl W, Weber K, Weber PC: Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488–1492 [DOI] [PubMed] [Google Scholar]
  • 59. Stephens NG, Parsons A, Schofield P, Kelly F, Cheeseman K, Mitchinson JM, Brown MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781–786 [DOI] [PubMed] [Google Scholar]
  • 60. Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO III: Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium‐de‐pendent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994; 24: 1611–1617 [DOI] [PubMed] [Google Scholar]
  • 61. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO III, Quyyumi AA, Panza JA: Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol 1995; 76: 1157–1161 [DOI] [PubMed] [Google Scholar]
  • 62. Walldius G, Ericson U, Olsson AG, Bergstrand L, Hadell K, Johansson J, Kaijser L, Lassvik C, Molgaard J, Nilsson S, Schafer‐Elinder L, Stenport G, Holme I: The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994; 74: 875–883 [DOI] [PubMed] [Google Scholar]
  • 63. Jha P, Rather M, Lonn E, Farkouh M, Yusuf S: The antioxidant vitamins and cardiovascular disease: A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860–872 [DOI] [PubMed] [Google Scholar]
  • 64. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE: Effects of high‐density lipoprotein on acetylcholine‐induced coronary vasoreactivity. Am J Cardiol 1991; 68: 1425–1430 [DOI] [PubMed] [Google Scholar]
  • 65. Heitzer T, Yla‐Herttuala S, Luoma J, Kurz S, Münzel T, Just H, Olschewski M, Drexler H: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: Role of oxidized LDL. Circulation 1996; 93: 1346–1353 [DOI] [PubMed] [Google Scholar]
  • 66. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE: Passive smoking and impaired endothelium‐dependent arterial dilation in healthy young adults. N Engl J Med 1996; 334: 150–154 [DOI] [PubMed] [Google Scholar]
  • 67. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Impaired endothelium‐dependent vasodilation in patients with essential hypertension: Evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 1994; 23: 1610–1616 [DOI] [PubMed] [Google Scholar]
  • 68. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH: Impaired endothelium‐mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19: 918–925 [DOI] [PubMed] [Google Scholar]
  • 69. Luscher TF, Vanhouette PM, Raij L: Antihypertensive treatment normalizes decreased endothelium‐dependent relaxations in rats with salt‐induced hypertension. Hypertension 1987; 9 (6, pt 2): III‐193–III‐197 [DOI] [PubMed] [Google Scholar]
  • 70. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium‐derived nitric oxide in the abnormal endothelium‐dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468–1474 [DOI] [PubMed] [Google Scholar]
  • 71. Panza JA, Quyyumi AA, Callahan TS, Epstein SE: Effect of antihypertensive treatment on endothelium‐dependent vascual relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145–1151 [DOI] [PubMed] [Google Scholar]
  • 72. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A: Effects of age on endothelium‐dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77–81 [DOI] [PubMed] [Google Scholar]
  • 73. Celermajer DS, Sorensen KE, Spiegalhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE: Aging is associated with endothelial dysfunction in healthy men years before the age‐related decline in women. J Am Coll Cardiol 1994; 24: 471–476 [DOI] [PubMed] [Google Scholar]
  • 74. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, Salvetti A: Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981–1987 [DOI] [PubMed] [Google Scholar]
  • 75. Taylor JA, Hand GA, Johnson DG, Seals DR: Augmented forearm vasoconstriction during dynamic exercise in healthy older men. Circulation 1992; 86: 1789–1799 [DOI] [PubMed] [Google Scholar]
  • 76. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52–60 [DOI] [PubMed] [Google Scholar]
  • 77. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole‐Wilson PA: 17B‐estradiol attenuates acetylcholine‐induced coronary arterial constriction in women but not in men with coronary heart disease. Circulation 1995; 92: 24–30 [DOI] [PubMed] [Google Scholar]
  • 78. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium‐dependent vasodilation in patients with insulin‐dependent diabetes mellitus. Circulation 1993; 88: 2510–2516 [DOI] [PubMed] [Google Scholar]
  • 79. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS: Oral L‐arginine inhibits platelet aggregation but does not enhance endothelium‐dependent dilation in healthy young men. J Am Coll Cardiol 1995; 26: 1054–1061 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES